• 1
    Billingham, ME, Cary, NR, Hammond, ME, Kemnitz, J, Marboe, C, McCallister, HA, Snovar, DC, Winters, GL, Zerbe, A (1990) A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Lung Transplant 9:587593.
  • 2
    Christ, E, Linka, A, Junga, G, Odermatt, M, Steinert, H, Kiowski, W, Schmid, C (1996) Bone density and laboratory parameters of bone metabolism in patients with terminal heart disease (in German). Schweiz Med Wochenschr 126:15531559.
  • 3
    Cummings, SR, Black, DM, Nevitt, MC, Browner, W, Cauley, J, Ensrud, K, Genant, HK, Palermo, L, Scott, J, Vogt, TM (1993) Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 341:7275.
  • 4
    Cvetkovic, M, Mann, GN, Romero, DF, Liang, XG, Ma, Y, Jee, WS, Epstein, S (1994) The deleterious effects of long-term cyclosporin A, cyclosporin G, and FK 506 on bone mineral metabolism in vivo. Transplantation 57:12311237.
  • 5
    De Maria, R, Minoli, L, Parolini, M, Gavazzeni, G, Gentile, M, Grossi, P, Livi, U, Parisi, F, Utili, R (1996) Prognostic determinants of six-month morbidity and mortality in heart transplant recipients. J Heart Lung Transplant 15:124135.
  • 6
    Fledelius, C, Johnsen, AH, Closs, PC, Bonde, M, Qvist, P (1997) Characterization of urinary degradation products derived from type I collagen. Identification of a β-isomerized Asp-Gly sequence within the C-terminal telopeptide (α1) region. J Biol Chem 272:97559763.
  • 7
    Garnero, P, Hausherr, E, Chapuy, M-C, Marcelli, C, Grandjean, H. Muller, C, Cormier, C, Bréart, G, Meunier, PJ, Delmas, PD (1996) Markers of bone resorption predict hip fracture risk in elderly women: the EPIDOS prospective study. J Bone Miner Res 11:15311538.
  • 8
    Garnero, P, Gineyts, E, Schaffer, AV, Seaman, J, Delmas, PD (1998) Measurement of urinary excretion of nonisomerized and β-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease. Arthritis Rheum 41:354360.
  • 9
    Garnero, P, Sornay-Rendu, E, Claustrat, B, Delmas, PD (2000) Biochemical markers of bone turnover, endogenous hormones, and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 15:15261536.
  • 10
    Genant, HK, Wu, CY, van Kuijk, C, Nevitt, MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:11371148.
  • 11
    Gineyts, E, Cloos, PAC, Borel, O, Grimaud, L, Delmas, PD (2000) Racemization and isomerization of type I collagen C-telopeptides in human bone and soft tissues: assessment of tissue turnover. Biochem J 345:481485.
  • 12
    Glendenning, P, Kent, GN, Adler, BD, Matz, L, Watson, I, O'Driscoll, GJ, Hurley, DM (1999) High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry. Clin Endocrinol 50:347355.
  • 13
    Guo, CY, Johnson, A, Locke, TJ, Eastell, R (1998) Mechanisms of bone loss after cardiac transplantation. Bone 22:267271.
  • 14
    Henderson, NK, Sambrook, PN, Kelly, PJ, Macdonald, P, Keogh, AM, Spratt, P, Eisman, JA (1995) Bone mineral loss and recovery after cardiac transplantation. Lancet 346:905.
  • 15
    Holzmüller, H, Benzer, W, Glöcklhofer, A, Metzler, W, Drexel, H (1996) Dezentrale umfassende Nachsorge nach Herztransplantation, 2 Jahre Erfahrung im Pilotprojekt Vorarlberg (abstract). Z Kardiol 85:363.
  • 16
    Kanis, JA, Melton, LJ, Christiansen, C, Johnston, CC, Khaltaev, N (1994) Perspective: the diagnosis of osteoporosis. J Bone Miner Res 9:11371141.
  • 17
    Krieg, MA, Seydoux, C, Sandini, L, Goy, JJ, Gillard Berguer, D, Thiébaud, D, Burckhardt, P (2001) Intravenous pamidronate as treatment for osteoporosis after heart transplantation a prospective study. Osteoporos Int 12:112116.
  • 18
    Lee, AH, Mull, RL, Keenan, GF, Callegari, PE, Dalinka, MK, Eisen, HJ, Mancini, DM, DiSiesa, VJ, Attie, MF (1994) Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med 96:3541.
  • 19
    Legrand, E, Chappard, D, Pascaretti, C, Duquenne, M, Rondeau, C, Simon, Y, Rohmer, V, Basle, MF, Audian, M (1999) Bone mineral density and vertebral fractures in men. Osteoporos Int 10:265270.
  • 20
    Leidig-Bruckner, G, Hosch, S, Dodidou, P, Ritschel, D, Conradt, C, Klose, C, Otto, G, Lange, R, Theilmann, L, Zimmermann, R, Pritsch, M, Ziegler, R (2001) Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet 357:342347.
  • 21
    Meys, E, Terreaux-Duvert, F, Beaume-Six, T, Dureau, G, Meunier, PJ (1993) Bone loss after cardiac transplantation: effects of calcium, calcidiol, and monofluorophosphate. Osteoporos Int 3:322329.
  • 22
    Movsowitz, C, Epstein, S, Fallon, M, Ismail, F, Thomas, S (1988) Cyclosporin A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology 123:25712577.
  • 23
    National Osteoporosis Foundation Working Group on Vertebral Fractures (1995) Report: assessing vertebral fractures. J Bone Miner Res 10:518523.
  • 24
    Oaks, TE, Wannenberg, T, Close, SA, Tuttle, LE, Kon, ND (2001) Steroid-free maintenance immunosuppression after heart transplantation. Ann Thorac Surg 72:102106.
  • 25
    Pagani, F, Bonett, G, Stefini, F, Panteghini, M (2000) Evaluation of a fully automated assay to measure C-telopeptide of type I collagen in serum. Clin Chem Lab Med 38:11111113.
  • 26
    Rodino, MA, Shane, E (1998) Osteoporosis after organ transplantation. Am J Med 104:459469.
  • 27
    Shane, E, Rivas, MC, Silverberg, SJ, Kim, TS, Staron, RB, Bilezikian, JP (1993) Osteoporosis after cardiac transplantation. Am J Med 94:257264.
  • 28
    Shane, E, Rivas, M, Staron, RB, Silverberg, SJ, Seibel, MJ, Kuiper, J, Mancini, D, Adesso, V, Michler, RE, Factor-Litvak, P (1996) Fracture after cardiac transplantation: a prospective longitudinal study. J Clin Endocrinol Metab 81:17401746.
  • 29
    Shane, E, Rivas, M, McMahon, DJ, Staron, RB, Silverberg, SJ, Seibel, MJ, Mancini, D, Michler, RE, Aaronson, K, Addesso, V, Hwa Lo, S (1997) Bone loss and turnover after cardiac transplantation. J Clin Endocrinol Metab 82:14971506.
  • 30
    Thiébaud, D, Krieg, MA, Gillard-Berguer, D, Jacquet, AF, Goy, JJ, Burckhardt, P (1996) Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation. Eur Clin Invest 26:549555.
  • 31
    van Staa, TP, Leufkens, HG, Abenhaim, L, Zhang, B, Cooper, C (2000) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 39:13831389.